InsiderClue
← All stocks

Crinetics Pharmaceuticals, Inc.

CRNX Net buying
CIK 0001658247 #989 in the set updated 19 Sep 2026
Bought (120 mo)
$62.80M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$95.80M
$8.89M on a plan · $42.83M straight out of an exercise
Sold at will
$44.09M
86 of 184 sales
Net
−$33.01M
+$18.71M against sales at will

By person

22 insiders · 216 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
PERCEPTIVE ADVISORS LLC entity
10% owner
$54.06M (5)
—
+$54.06M
5,321,032
5.02%
$212.84M
+1,630%
Struthers Richard Scott
President & CEO
$65.00K (2)
$23.19M (23) scheduled
−$23.12M
111,100
0.1047%
$4.44M
−91.6%
Vivo Capital VIII, LLC entity
10% owner
$6.58M (4)
$19.81M (34)
−$13.24M
298,625
0.2815%
$11.95M
—
5AM Ventures IV, L.P. entity
Former 10% holder
$1.96M (2)
$15.04M (6)
−$13.08M
94,489
0.0891%
$3.78M
—
Betz Stephen F.
Chief Scientific Officer
—
$8.75M (53) scheduled
−$8.75M
0
0.0000%
$0.00
−100.0%
Pizzuti Dana
Chief Med and Dev Officer
—
$7.11M (21) scheduled
−$7.11M
66,837
0.0630%
$2.67M
+1,584%
Knight Jeff E.
Chief Dev. & Operating Officer
—
$7.04M (11) scheduled
−$7.04M
105,289
0.0993%
$4.21M
+2,375%
Wilson Marc
CFO
—
$6.64M (9) scheduled
−$6.64M
111,092
0.1047%
$4.44M
+69.9%
Fust Matthew K
Director
—
$4.24M (12) scheduled
−$4.24M
0
0.0000%
$0.00
−100.0%
Hassard James
Chief Commercial Officer
—
$1.33M (2) scheduled
−$1.33M
29,259
0.0276%
$1.17M
—
Okey Stephanie
Director
—
$1.18M (4) scheduled
−$1.18M
0
0.0000%
$0.00
—
Madan Ajay
Chief Development Officer
—
$418.00K (2)
−$418.00K
176,995
0.1669%
$7.08M
+189.8%
Krasner Alan Seth
Chief Medical Officer
$34.00K (1)
$352.08K (2) scheduled
−$318.08K
43,210
0.0407%
$1.73M
+372.4%
Schilke Tobin
Chief Financial & Infra. Ofcr.
—
$266.30K (1) scheduled
−$266.30K
0
0.0000%
$0.00
−100.0%
Vivaldi Coelho Rogerio
Director
$110.30K (1)
$300.76K (3) scheduled
−$190.46K
0
0.0000%
$0.00
—
Kalofonos Isabel
Chief Commercial Officer
—
$137.50K (1) scheduled
−$137.50K
0
0.0000%
$0.00
−100.0%
WIERENGA WENDALL
Director
—
—
—
116,146
0.1095%
$4.65M
+55.9%
WIERENGA WENDELL
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Deardorf Caren
Director
—
—
—
0
0.0000%
$0.00
—
Nichols Weston
Director
—
—
—
0
0.0000%
$0.00
—
Bedrosian Camille L
Director
—
—
—
0
0.0000%
$0.00
—
Versant Venture Capital V, L.P. entity
10% owner
—
—
—
0
0.0000%
$0.00
—

Individual transactions

46
Insider
Date
Role
Action
Shares
Price
Amount
Vivaldi Coelho Rogerio
2 Jul 2026
Director
Sold on a plan
3,000
$40.00
$120.00K
Okey Stephanie
17 Jun 2026
Director
Sold on a plan
608
$36.22
$22.02K
Okey Stephanie
17 Jun 2026
Director
Sold on a plan
6,292
$35.62
$224.12K
Struthers Richard Scott
16 Mar 2026
President & CEO
Sold on a plan
8,785
$37.77
$331.81K
Struthers Richard Scott
16 Mar 2026
President & CEO
Sold on a plan
13,196
$37.11
$489.70K
Betz Stephen F.
16 Mar 2026
Chief Scientific Officer
Sold on a plan
4,241
$37.77
$160.18K
Betz Stephen F.
16 Mar 2026
Chief Scientific Officer
Sold on a plan
6,371
$37.11
$236.43K
Knight Jeff E.
16 Mar 2026
Chief Operating Officer
Sold on a plan
3,961
$37.77
$149.61K
Knight Jeff E.
16 Mar 2026
Chief Operating Officer
Sold on a plan
5,950
$37.11
$220.80K
Vivaldi Coelho Rogerio
12 Mar 2026
Director
Sold on a plan
523
$36.77
$19.23K
Vivaldi Coelho Rogerio
12 Mar 2026
Director
Sold on a plan
4,477
$36.08
$161.53K
Schilke Tobin
3 Mar 2026
Chief Financial Officer
Sold on a plan
6,713
$39.67
$266.30K
Okey Stephanie
3 Mar 2026
Director
Sold on a plan
3,000
$39.67
$119.01K
Struthers Richard Scott
26 Sep 2025
President & CEO
Sold on a plan indirect
4,000
$45.00
$180.00K
Pizzuti Dana
20 Aug 2025
Chief Med and Dev Officer
Sold on a plan
6,492
$29.18
$189.44K
Struthers Richard Scott
19 Mar 2025
President & CEO
Sold on a plan
875
$34.83
$30.48K
Struthers Richard Scott
19 Mar 2025
President & CEO
Sold on a plan
16,463
$34.17
$562.54K
Betz Stephen F.
19 Mar 2025
Chief Scientific Officer
Sold on a plan
291
$34.83
$10.14K
Betz Stephen F.
19 Mar 2025
Chief Scientific Officer
Sold on a plan
5,479
$34.17
$187.22K
Knight Jeff E.
19 Mar 2025
Chief Operating Officer
Sold on a plan
361
$34.83
$12.57K
Knight Jeff E.
19 Mar 2025
Chief Operating Officer
Sold on a plan
6,801
$34.17
$232.39K
Pizzuti Dana
19 Mar 2025
Chief Med and Dev Officer
Sold on a plan
127
$34.83
$4.42K
Pizzuti Dana
19 Mar 2025
Chief Med and Dev Officer
Sold on a plan
2,388
$34.17
$81.60K
Struthers Richard Scott
2 Dec 2024
President & CEO
Sold on a plan indirect
10,000
$57.57
$575.70K
Knight Jeff E.
22 Nov 2024
Chief Operating Officer
Sold on a plan
501
$56.52
$28.32K
Betz Stephen F.
10 Sep 2024
Chief Scientific Officer
Sold on a plan
1,035
$51.50
$53.30K
Betz Stephen F.
26 Aug 2024
Chief Scientific Officer
Sold on a plan
3,000
$53.19
$159.57K
Betz Stephen F.
12 Aug 2024
Chief Scientific Officer
Sold on a plan
3,000
$47.68
$143.04K
Betz Stephen F.
25 Jul 2024
Chief Scientific Officer
Sold on a plan
3,000
$53.43
$160.29K
Betz Stephen F.
10 Jul 2024
Chief Scientific Officer
Sold on a plan
3,000
$48.55
$145.65K
Knight Jeff E.
26 Jun 2024
Chief Operating Officer
Sold on a plan
956
$44.38
$42.43K
Betz Stephen F.
25 Jun 2024
Chief Scientific Officer
Sold on a plan
3,000
$45.37
$136.11K
Betz Stephen F.
10 Jun 2024
Chief Scientific Officer
Sold on a plan
3,000
$43.86
$131.58K
Betz Stephen F.
28 May 2024
Chief Scientific Officer
Sold on a plan
3,000
$47.49
$142.47K
Betz Stephen F.
10 May 2024
Chief Scientific Officer
Sold on a plan
3,000
$49.43
$148.29K
Wilson Marc
19 Mar 2024
CFO
Sold on a plan
6,942
$42.91
$297.88K
Betz Stephen F.
25 Jan 2024
Chief Scientific Officer
Sold on a plan
3,000
$37.26
$111.78K
Betz Stephen F.
10 Jan 2024
Chief Scientific Officer
Sold on a plan
3,000
$37.65
$112.95K
Betz Stephen F.
26 Dec 2023
Chief Scientific Officer
Sold on a plan
3,000
$35.89
$107.67K
Betz Stephen F.
11 Dec 2023
Chief Scientific Officer
Sold on a plan
3,000
$32.87
$98.61K
Betz Stephen F.
27 Nov 2023
Chief Scientific Officer
Sold on a plan
3,000
$31.84
$95.52K
Struthers Richard Scott
13 Jul 2023
President & CEO
Sold on a plan indirect
14,157
$20.35
$288.09K
Struthers Richard Scott
12 Jul 2023
President & CEO
Sold on a plan indirect
11,459
$20.17
$231.13K
Struthers Richard Scott
11 Jul 2023
President & CEO
Sold on a plan indirect
24,384
$20.14
$491.09K
Struthers Richard Scott
16 Jun 2023
President & CEO
Sold on a plan indirect
50,000
$20.81
$1.04M
Pizzuti Dana
5 Apr 2023
Chief Development Officer
Sold on a plan
8,212
$16.15
$132.62K
Show all 216 transactions →

What was left out

Form 4 filings counted 272
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 20
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 52
Sales at will 86
Transactions with no price 0
Shares from compensation/vesting 22,218,718
Sales filed before the plan box existed 86
History held since 20 Jul 2018